An SiO2/ZnBr2 mediated expeditious approach to 3-methyl-1-phenyl-1H-pyrazol-5(4H)-one derivatives in water under microwave irradiation

Mehtab Parveen*a, Shaista Azaza, Ali Mohammed Mallaa, Faheem Ahmada, Musheer Ahmadbc and Mayank Guptab
aDivision of Organic Synthesis, Department of Chemistry, Aligarh Muslim University, Aligarh, 202002, India. E-mail: mehtab.organic2009@gmail.com; Tel: +91-9897179498
bDepartment of Chemistry, Indian Institute of Technology Kanpur, 208016, India
cDepartment of Applied Chemistry, Aligarh Muslim University, Aligarh 202002, India

Received 12th October 2015 , Accepted 11th December 2015

First published on 15th December 2015


Abstract

A new one-pot three-component green approach has been developed for the synthesis of a series of pyrazolone derivatives 2(a–s) from differently substituted aromatic aldehydes, ethylacetoacetate and phenylhydrazine/2,4-dinitrophenylhydrazine in excellent yields (94–98%), employing SiO2/ZnBr2 as a recyclable Lewis acid catalyst in water under microwave heating. The molecular structure of compounds 2a and 2d were well supported by single crystal X-ray crystallographic analysis. The present protocol bears a wide substrate tolerance and is believed to be more practical, efficient, eco-friendly and compatible as compared to existing methods.


Introduction

In the last few decades application of clean technologies in chemical synthesis has turned out to be a major area of research in green chemistry.1 Eco-friendly and reusable heterogeneous catalysts have been the major constituents for providing such clean technologies. Due to rapid advances in medicinal chemistry, great attention has been paid towards the development of novel clean processes employing nontoxic reagents, catalysts and solvents.2

Pyrazolone derivatives are an important class of heterocyclic compounds as they play a vital role both in medicinal chemistry and in organic synthesis.3 These compounds exhibit remarkable pharmaceutical properties such as analgesic, antitubercular, antimicrobial, anti-inflammatory and antioxidant.4–8 Moreover compounds possessing pyrazolones moiety are gaining much importance especially in drug discovery programs9 and have been used as cardiotonics,10,11 anticancer (TELIN)12 and as potent inhibitors of the enzyme GSK3b.13 Pyrazolones are traditionally synthesized by treatment of δ-keto esters with hydrazine substrates under acidic conditions.14 A number of alternative methods have been documented in the literature for the synthesis of pyrazolone derivatives such as solid-state condensation,15 electrocatalytic procedure16 and ultrasonic irradiation technique17 for this synthesis. Moreover, Rajeev and co-workers reported its synthesis under microwave irradiation18 (Scheme 1). Various catalysts have also been used for the preparation of these compounds via the condensation reaction. These catalysts include acetic acid or piperidine,19 silica-bonded S-sulfonic acid,20 sodium dodecyl sulfate,21 CAN,22 and ETBA.23 Nowadays a great deal of interest has been placed towards the reactions in presence of water.24 Breslow and Lindström reported that hydrophobic effect of water is responsible for the organic reaction.25,26 Although the reported protocol has lots of significance in advance chemistry due to cheap, nontoxic and nonflammable nature of water, serves as environmentally benign solvent and good yields of the products, but long reaction time and solubility of the substrate makes it less applicable. Moreover the combination of water with microwaves has lead to the development of rapid, effective and environmentally benign synthetic methodologies.27 To the best of our knowledge silica supported zinc bromide (SiO2/ZnBr2) has not been used as a catalyst for the synthesis of 3-methyl-1-phenyl-1H-pyrazol-5(4H)-one derivatives. As a part of our research program on the development of new synthetic methods28–30 under the aspects of green chemistry, herein, we report for the first time the development of an efficient, economical and recyclable silica supported ZnBr2 promoted synthesis of pyrazolone derivatives in excellent yields via three component reaction of aromatic aldehydes, ethylacetoacetate and phenylhydrazine/2,4-dinitrophenylhydrazine (2,4-DNP) in water under microwave heating.


image file: c5ra21146h-s1.tif
Scheme 1 Synthetic route for pyrazolone using microwave.

The SiO2/ZnBr2 catalyst has emerged as a promising heterogeneous solid catalyst for various organic transformations. Keivanloo et al. exploited SiO2/ZnBr2 for the synthesis of ynones31 by cross-coupling of acid chloride with terminal alkynes and synthesis of 4,5-disubstituted 1,2,3-(NH)-triazoles.32 Moreover, Kodomari and co-workers33 also reported the synthesis of triarylmethanes and 9,10-diarylanthracenes and Clark et al.34 reported bromination of aromatic substrate using SiO2/ZnBr2 catalyst. The catalyst possesses inherent environmentally benevolent properties such as non-toxicity, biocompatibility, physiological inertness, recyclability, inexpensiveness and thermal stability. The catalyst was prepared by employing standard procedures depicted in the literature31 and recycled up to six runs. The formation of SiO2/ZnBr2 system was evaluated by FT-IR, powder XRD and SEM-EDX analysis. The stability of the catalyst was shown by TGA/DTA analysis.

Results and discussion

Characterization of catalyst (SiO2/ZnBr2)

The FT-IR spectrum of the catalyst (SiO2/ZnBr2) is depicted in Fig. 1. The FT-IR spectrum of the catalytic system displayed a symmetrical stretching band at 3483.37 cm−1 for hydroxyl group and the band resonating at 1632 cm−1 was attributed to the bending vibration of adsorbed water.35 Moreover, asymmetric and symmetric stretching vibration band for Si–O–Si appeared at 1093.14 cm−1 and 797.12 cm−1, respectively. In addition the peak resonating at 910 and 467.53 cm−1 has been assigned for the stretching vibration of Si–OH35 and Zn–Br, respectively. Thus, FT-IR spectrum of the catalytic system authenticates the coating of ZnBr2 on the SiO2 surface as all the characteristic peaks related to silica and ZnBr2 has been present in the spectrum of SiO2/ZnBr2.
image file: c5ra21146h-f1.tif
Fig. 1 FT-IR Spectrum of catalyst (SiO2/ZnBr2).

Formation of the catalytic system (SiO2/ZnBr2) was further confirmed by powder XRD analysis (Fig. 2). X-ray diffractograms (XRD) of the catalyst were recorded in the 2θ range of 20–80°. A single broad peak in the range of 2θ = 20–30° ascribed to the amorphous nature of silica. The characteristic diffraction peaks of pure ZnBr2 were reported to appear at 13.7°, 21.1°, 27.5°, 46.1° and 53.4°.36 The XRD analysis of SiO2/ZnBr2 exhibited diffraction peak for ZnBr2 only at 46.2° and 53.4°. However, the other characteristic peaks (21.1° and 27.5°) were merged with the broad peak of SiO2 (2θ = 20–30°). The appearance of these characteristics peaks indicating the dispersion of ZnBr2 on the silica material and thus confirming the formation of SiO2/ZnBr2 matrix.


image file: c5ra21146h-f2.tif
Fig. 2 Powder XRD pattern of catalyst (SiO2/ZnBr2).

SEM analysis was employed to study the surface morphology of the catalytic system (Fig. 3). SEM micrographs of the catalyst showed that the particles of ZnBr2 were well dispersed on silica surface. The 3D surface plot (Fig. S1) (ESI) of pure silica and SiO2/ZnBr2 were provided to further verify the adsorption of ZnBr2 on silica surface. The white area of plot in Fig. S1(b) confirmed the successful adsorption of ZnBr2 on the silica surface. The successful incorporation of zinc bromide was also confirmed by EDX analysis (Fig. 4). EDX spectrum showed the presence of Zn and Br in addition to O and Si elements.


image file: c5ra21146h-f3.tif
Fig. 3 SEM micrograph of (a) pure SiO2 (b) SiO2/ZnBr2 catalyst.

image file: c5ra21146h-f4.tif
Fig. 4 EDX analysis of the catalyst (SiO2/ZnBr2).

The thermal stability of the catalyst was determined by TGA analysis (Fig. 5). The only weight loss of 16.94% in the range of 40–120 °C was attributed to loss of physically adsorbed water molecules in the silica gel framework. TGA is further supported by DTA analysis in which a prominent peak at 93.04 °C showed endothermic reaction which help in the removal of water molecule (Fig. 5). Further there is no weight loss upto 800 °C. Therefore it can be concluded that physiosorbed and chemisorbed ZnBr2 on silica surfaces is stable upto 800 °C.37


image file: c5ra21146h-f5.tif
Fig. 5 TGA/DTA of catalyst (SiO2/ZnBr2).

Optimization of reaction condition

In the present study a series of 3-methyl-1-phenyl-1H-pyrazol-5(4H)-one derivatives 2(a–s) have been synthesized (Scheme 2), via a facile environmentally benign cyclization reaction, involving various aromatic aldehydes with ethylacetoacetate and phenylhydrazine/2,4-dinitrophenylhydrazine (2,4-DNP) to yield target 3-methyl-1-phenyl-1H-pyrazol-5(4H)-one derivatives in excellent yields (94–98%) with high purity.
image file: c5ra21146h-s2.tif
Scheme 2 Synthetic scheme for the synthesis of pyrazolone derivatives 2(a–s).

To optimize the best reaction condition for these transformations, we investigate the solvent effect, catalyst loading, effect of temperature and recyclability of the catalyst on the model reaction. Initially, indole-3-carbaldehyde (1a, 2 mmol), phenylhydrazine (2 mmol) and ethylacetoacetate (2 mmol) were refluxed in water (10 mL) at 60 °C without any catalyst. The reaction took a longer time period of 24 h to complete and afforded desired product 2a in less yield (Table 1, entry 1), signifying the need of a catalyst. The reaction was then studied in the presence of different catalysts such as AlCl3, ZnBr2, FeCl3, SiO2–Cl, SiO2/ZnBr2. Our analysis revealed that the catalytic activity of various catalysts in water at 60 °C was found to be in the order of SiO2/ZnBr2 > AlCl3 > FeCl3 > ZnBr2 > SiO2–Cl (Table 1, entries 2–6). To compare the efficiency as well as competence of the reactions under aqueous condition, the model reaction was also examined in the presence of SiO2/ZnBr2 in different solvents like MeOH, EtOH, CH3COOH, CH2Cl2, DMF and THF. The use of relatively less polar aprotic solvents CH2Cl2, DMF and THF yielded the product 2a in moderate yield (58–62%), after extended reaction time (Table 1, entries 10–12). However, in polar protic solvents MeOH, EtOH, and AcOH relatively high yield (65–70%) of the product 2a was obtained with dip in reaction time (Table 1, entries 7–9), whereas when reaction was performed in water in the presence of SiO2/ZnBr2, there was remarkable increase in the yield (86%) of the product 2a with prominent fall in reaction time (Table 1, entry 6). In order to further improve the protocol to make it more energy efficient we introduced microwaves. The use of microwaves (Anton Paar, Monowave 300) enhanced the protocol remarkably with high yield of the product 2a (98%) and short reaction period (10 min) (Table 1, entry 13).

Table 1 Effect of different reaction media on model reaction (2a)a
S. No. Solvent Condition Timeb (h) Yieldc (%)
a Reaction condition: indole-3-carbaldehyde (1a, 2 mmol), phenylhydrazine (2 mmol), and ethylacetoacetate (2 mmol), different solvent (10 mL), different catalyst (0.10 g).b Reaction progress monitored by TLC.c Isolated yield of products.
1 Water 60 °C, without catalyst 24 h 46
2 Water 60 °C, AlCl3 8 h 56
3 Water 60 °C, ZnBr2 10 h 52
4 Water 60 °C, FeCl3 12 h 53
5 Water 60 °C, SiO2–Cl 16 h 51
6 Water 60 °C, SiO2/ZnBr2 4 h 86
7 MeOH 60 °C, SiO2/ZnBr2 6 h 65
8 EtOH 60 °C, SiO2/ZnBr2 8 h 70
9 CH3COOH 60 °C, SiO2/ZnBr2 6 h 68
10 CH2Cl2 60 °C, SiO2/ZnBr2 10 h 62
11 DMF 60 °C, SiO2/ZnBr2 14 h 60
12 THF 60 °C, SiO2/ZnBr2 18 h 58
13 Water 60 °C, SiO2/ZnBr2, MW 10 min 98


To achieve the optimum concentration of the catalyst, the model reaction (2a) was investigated at different concentrations 0.02–0.12 g (Table 2, entries 1–6) of the catalyst SiO2/ZnBr2 at 60 °C in water under MW. The best results were obtained with the use of 0.10 g of catalyst. Using less than 0.10 g of catalyst, moderate yields of the product 2a (66–83%) were obtained with extended reaction times, while increasing catalyst amount 0.10–0.12 g, there was no further increase in the yield of the product 2a, possibly due to the saturation of the catalyst. The above results signify that 0.10 g of SiO2/ZnBr2 is optimum dose in terms of efficient yield and reduced reaction time.

Table 2 Effect of catalyst loading on the yield and reaction time of model reaction (2a)a
Entry Catalyst (g) Timeb (min) Yieldc (%)
a Reaction condition: indole-3-carbaldehyde (1a, 2 mmol), phenylhydrazine (2 mmol), and ethylacetoacetate (2 mmol), water (10 mL), SiO2/ZnBr2 (0.02–0.12 g), MW-60 °C.b Reaction progress monitored by TLC.c Isolated yield of products.
1 0.02 35 60
2 0.04 30 68
3 0.06 28 75
4 0.08 25 83
5 0.10 10 98
6 0.12 10 98


To optimize the reaction temperature, the model reaction was carried out at different temperatures in water under microwave heating (Table 3, entries 1–7). It was observed that increase in temperature from 25 °C to 60 °C, has a noteworthy effect on the model reaction in terms of yield and reaction time (Table 3, entries 1–6). However, no further enhancement in the yield of product 2a was observed when the reaction temperature was raised from 60 °C to 65 °C (Table 3, entry 7).

Table 3 Effect of reaction temperature on the model reaction (2a)a
Entry Temperature (°C) Timeb (min) Yieldc (%)
a Reaction condition: indole-3-carbaldehyde (1a, 2 mmol), phenylhydrazine (2 mmol), and ethylacetoacetate (2 mmol), water (10 mL), SiO2/ZnBr2 (0.10 g), MW, different temperature (25–65 °C).b Reaction progress monitored by TLC.c Isolated yield of products.
1 25 75 72
2 40 50 74
3 45 35 78
4 50 30 84
5 55 25 88
6 60 10 98
7 65 10 98


After optimization of the reaction conditions, the catalyst SiO2/ZnBr2 was examined under the optimized reaction conditions using both conventional and microwave heating. A wide range of aromatic aldehydes reacted with ethylacetoacetate and phenylhydrazine to afford the target pyrazolone in excellent yields. We Further explored this devised protocol using 2,4-dinitrophenylhydrazine (2,4-DNP) to expand its product diversity and scope (Table 4). The catalyst showed good efficiency under conventional heating giving the products in 4–6 h. However, microwave induction produced excellent yields (94–98%) of products in 10–15 min. The above results demonstrate that SiO2/ZnBr2 is an efficient catalyst for the synthesis of wide range of pyrazolones in high yields under mild aqueous conditions.

Table 4 Synthesis of pyrazolones derivatives 2(a–s)
S. No. Products Conventional Methoda Microwave irradiationb
Timec (h) Yieldd (%) Timec (min) Yieldd (%)
a Reaction condition: differently substituted aromatic aldehydes 1(a–s) (2 mmol), phenylhydrazine/2,4-DNP (2 mmol), and ethylacetoacetate (2 mmol), water (10 mL), SiO2/ZnBr2 (0.10 g), 60 °C.b Reaction condition: differently substituted aromatic aldehydes 1(a–s) (2 mmol), phenylhydrazine/2,4-DNP (2 mmol), and ethylacetoacetate (2 mmol), water (10 mL), SiO2/ZnBr2 (0.10 g), MW-60 °C.c Reaction progress monitored by TLC.d Isolated yield of the products.
2a image file: c5ra21146h-u1.tif 4 81 10 98
2b image file: c5ra21146h-u2.tif 4.5 77 10 95
2c image file: c5ra21146h-u3.tif 4.5 80 15 98
2d image file: c5ra21146h-u4.tif 4 84 10 98
2e image file: c5ra21146h-u5.tif 5 78 15 95
2f image file: c5ra21146h-u6.tif 4.5 82 15 96
2g image file: c5ra21146h-u7.tif 6 79 15 94
2h image file: c5ra21146h-u8.tif 5.0 76 15 95
2i image file: c5ra21146h-u9.tif 5.5 81 10 97
2j image file: c5ra21146h-u10.tif 6.0 74 15 94
2k image file: c5ra21146h-u11.tif 4 83 10 97
2l image file: c5ra21146h-u12.tif 4.5 75 10 94
2m39 image file: c5ra21146h-u13.tif 5.5 84 10 98
2n39 image file: c5ra21146h-u14.tif 5 76 15 96
2o40 image file: c5ra21146h-u15.tif 6 74 15 94
2p41 image file: c5ra21146h-u16.tif 4.5 78 10 97
2q40 image file: c5ra21146h-u17.tif 5 76 15 95
2r40 image file: c5ra21146h-u18.tif 4 82 10 98
2s41 image file: c5ra21146h-u19.tif 5.5 75 15 94


Chemistry

The structural elucidation of the synthesized compounds 2(a–s) was established on the basis of elemental analysis (IR, 1H NMR, 13C NMR) and mass spectral studies. The analytical results for C, H and N were within ±0.3% of the theoretical values. The absence of peak for aldehydic carbonyl in IR spectrum, confirmed the reaction at the carbonyl moiety. Moreover, all the compounds displayed a characteristic peak for C[double bond, length as m-dash]N and C[double bond, length as m-dash]O groups, resonating at around 1578–1603 cm−1 and 1680–1700 cm−1, respectively, which signifies the formation of a pyrazolone ring. Characteristic peaks for the different functional groups such as methoxy, nitro and hydroxyl etc. have been discussed in Experimental section. In 1H NMR spectrum, each compound displayed a sharp singlet at around δ 7.32–7.99 ascribed to the olefinic proton, a broad singlet at around 12.02–12.46 (D2O exchangeable) has been ascribed to –NH proton of indole ring. Similarly, a sharp singlet at around 9.32–9.82 corresponds to the H-2 proton of indole ring (2a–2c). Furthermore, sharp singlets resonating at around δ 10.64, 10.04, 10.12, 10.10 each integrating for one proton, has been attributed to H-2 protons of γ-pyrone ring of chromones 2d, 2e, 2f and 2g respectively. 13C NMR spectra, showed a series of signals resonating at around δ 105.13–162.18 which have been assigned to aromatic carbons, peaks resonating at around δ 137.31–153.80 and δ 163.05–170.16 corresponds to –C[double bond, length as m-dash]N and –C[double bond, length as m-dash]O moiety of pyrazolone ring, respectively. Similarly signals at δ 174.19–174.69 have been attributed to carbonyl group (C[double bond, length as m-dash]Oγ-pyrone) of compounds (2d–2h). The mass spectral analysis of the synthesized compounds was also in good conformity with the proposed structures. The selective Z-geometry across C[double bond, length as m-dash]C was authenticated by single crystal X-ray crystallographic analysis of compound 2a and 2d (Fig. 6), which was found to be stabilized by an intricate array of H-bonding (Fig. 7) and π⋯π interactions (Fig. 8). The crystallographic data of compound 2a and 2d have been presented in Table 5. Moreover, the selected bond distances (Å), bond angles (°) and packing diagram of compound 2a and 2d are shown in Tables S1 and S2 and Fig. S2–S4 (ESI).
image file: c5ra21146h-f6.tif
Fig. 6 Asymmetric unit showing thermal ellipsoids (50% probability level) of (a) compound 2a (b) compound 2d.

image file: c5ra21146h-f7.tif
Fig. 7 2D view showing intricate H-bonding interactions in (a) compound 2a (b) compound 2d.

image file: c5ra21146h-f8.tif
Fig. 8 Diagrammatic representation of π⋯π interactions in (a) compound 2a, π⋯π and –CH …π interactions in (b) compound 2d.
Table 5 Crystallographic data and structure refinement of compounds 2a and 2d
Parameters Compound 2a Compound 2d
a GOF is defined as {∑[w(Fo2Fc2)]/(np)}1/2 where n is the number of data and p is the number of parameters.b R = {∑||Fo| − |Fc||/∑|Fo|}, wR2 = {∑w(Fo2Fc2)2/∑w(Fo2)2}1/2.
Empirical formula C19H15N3O C20H14N2O3
Formula wt 301.34 330.33
Crystal system Monoclinic Triclinic
Space group P21/n P[1 with combining macron]
a, Å 5.810(5) 7.870(5)
b, Å 9.256(5) 8.298(3)
c, Å 26.893(5) 11.843(5)
α (°) 90 85.806(4)
β (°) 94.997(5) 80.900(5)
γ (°) 90 89.987(5)
U, Å3 1440.7(15) 761.6(7)
Z 4 2
ρcalc Mg m−3 1.389 1.441
μ, mm−1 0.089 0.099
Temperature (K) 100 100
θ max 25.50 25.50
F(000) 632 344
Refl. collected 11[thin space (1/6-em)]010 9548
Independent refl. 2087 2314
GOFa 1.038 1.037
Final Rb indices [I > 2σ(I)] R1 = 0.0501 wR2 = 0.1268 R1 = 0.0402 wR2 = 0.0970
R indices (all data) R1 = 0.0675 wR2 = 0.1380 R1 = 0.0524 wR2 = 0.1038


Reusability of the catalyst

The reusability of the catalyst (SiO2/ZnBr2) was also explored for the selected model reaction in order to reduce the cost of the process (Fig. 9). After the first fresh run with 98% yield, the catalyst was removed by simple filtration, washed with ethylacetate and dried at 160 °C for 10 h. The recovered catalyst was further tested up to five more reaction cycles. The results revealed that there is little drop in the yield of the product after every successive run of the catalyst. This little drop in the catalytic activity is believed to be due to the leaching of ZnBr2. SEM and EDX analysis of the recovered catalyst was also performed to ascertain its morphology and composition (Fig. S4). It was observed that the composition of the catalytic system was almost consistent with the fresh catalyst (Fig. 3) and there have been no significant changes in the morphology of the catalyst.
image file: c5ra21146h-f9.tif
Fig. 9 Recycling data of the catalyst (SiO2/ZnBr2) for the model reaction.

Experimental

Materials and general methods

All the chemicals and reagents were purchased from Merck and Sigma-Aldrich (India) as ‘synthesis grade’ and used without further purification. The microwave synthesis was performed in Anton Paar, Monowave 300 microwave synthesizer. Melting points were determined on a Kofler apparatus and are uncorrected. Elemental analysis (C, H, N) was conducted using Carlo Erba analyzer model 1108. The IR spectra were recorded with a Shimadzu IR-408 Perkin-Elmer1800 instrument (FTIR) and the values are given in cm−1. 1H NMR and 13C NMR spectra were run in DMSO-d6/CDCl3 on a Bruker Avance-II 400 MHz instrument with TMS as an internal standard and J values were measured in Hertz (Hz). Chemical shifts are reported in ppm (δ) relative to TMS. Mass spectra were recorded on a JEOL D-300 mass spectrometer. X-ray diffractograms (XRD) of the catalyst were recorded in the 2θ range of 20–80° with a scan rate of 41 min−1 on a Shimadzu-6100 X-ray diffractometer with Ni-filtered Cu Kα radiation at a wavelength of 1.54060 Å. The scanning electron microscope (SEM-EDX) analysis was obtained using a JEOL (JSM-6510) equipped with an energy dispersive X-ray spectrometer at different magnification. TGA has been carried out with DTG-60H (Simultaneous DTA-TG Apparatus), Shimadzu instrument. Thin layer chromatography (TLC) glass plates (20 × 5 cm) were coated with silica gel G (Merck) using benzene–acetone (8[thin space (1/6-em)]:[thin space (1/6-em)]2) mixture as mobile phase and exposed to iodine vapors to check the homogeneity as well as the progress of the reaction.

Preparation of the silica-supported zinc bromide (SiO2/ZnBr2) catalyst

Silica gel (70–230 mesh) (10 g) was added to a solution of ZnBr2 (12 mmol, 2.7 g) in EtOH (50 mL), and the mixture was heated at reflux for 1 h. The solvent was removed using rotary evaporator, and the product was dried under vacuum at 160 °C for 10 h.31 The other catalyst i.e. SiO2–Cl used for the comparative study has been synthesized according to the previously published standard procedures.38

General procedure for the synthesis of pyrazolones under microwave irradiation

A mixture of substituted aromatic aldehyde (2 mmol), ethylacetoacetate (2 mmol), phenylhydrazine/2,4-Dinitrophenylhydrazine (2 mmol) and catalyst (0.10 g) in 10 mL water was taken in a G30 vial and irradiated using microwaves with continuous stirring at 60 °C for 10–15 min. After completion of reaction (monitored by TLC), the reaction mixture was allowed to cool at room temperature and diluted with cold water (5 mL). The catalyst was separated by filtration and the resulting solution was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were washed with brine, dried over anhydrous Na2SO4 and evaporated under reduced pressure. The crude product was crystallized with chloroform–methanol to afford the pure product. The recovered catalyst was reused for subsequent cycles without a significant loss in yield.

Spectral characterization

(Z)-4-((1H-Indol-3-yl)methylene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (2a). Orange crystalline solid, yield 98%, mp 245–250 °C. IR (KBr, cm−1): 1157, 1456 (C[double bond, length as m-dash]Caromatic), 1594 (C[double bond, length as m-dash]N), 1680 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.19–7.96 (m, 5H, phenyl ring), 7.9 (s, 1H, –C[double bond, length as m-dash]H), 12.46 (brs, 1H, –NH, D2O exchangeable), 7.14–7.67 (m, 4H, indole ring), 2.39 (s, 3H, –CH3), 9.82 (s, 1H, indole ring). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 165.65 (C[double bond, length as m-dash]O), 133.44 (C[double bond, length as m-dash]C), 147.89 (–C[double bond, length as m-dash]N), 143.23 (–C[double bond, length as m-dash]H), 118.24–140.54 (phenyl ring), 111.64–137.65 (indole ring), 12.93 (CH3). Analytical cal. C19H15N3O: C, 75.73; H, 5.02; N, 13.94; found: C, 75.70; H, 5.03; N, 13.96. MS (EI): (m/z) [M+˙] 301.12.
(Z)-4-((5-Hydroxy-1H-indol-3-yl)methylene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (2b). Yellow crystalline solid, yield 95%, mp 256 °C. IR (KBr, cm−1): 1150, 1450 (C[double bond, length as m-dash]Caromatic), 1578 (C[double bond, length as m-dash]N), 1685 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.23–7.98 (m, 5H, phenyl ring), 7.83 (s, 1H, –C[double bond, length as m-dash]H), 11.22 (brs, 1H, –NH, D2O exchangeable), 6.86–7.17 (m, 3H, indole ring), 2.31 (s, 3H, –CH3), 9.70 (s, 1H, indole ring), 10.20 (s, 1H, –OH, D2O exchangeable). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 165.63 (C[double bond, length as m-dash]O), 133.44 (C[double bond, length as m-dash]C), 147.89 (–C[double bond, length as m-dash]N), 143.23 (–C[double bond, length as m-dash]H), 118.20–140.51 (phenyl ring), 111.64–137.65 (indole ring), 13.15 (CH3). Analytical cal. C19H15N3O2: C, 71.91; H, 4.76; N, 13.24; found: C, 71.90; H, 4.79; N, 13.22. MS (EI): (m/z) [M+˙] 317.12.
(Z)-3-Methyl-4-((5-methyl-1H-indol-3-yl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one (2c). Yellow solid, yield 98%, mp 248 °C. IR (KBr, cm−1): 1152, 1452 (C[double bond, length as m-dash]Caromatic), 1603 (C[double bond, length as m-dash]N), 1688 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.26–7.91 (m, 5H, phenyl ring), 7.71 (s, 1H, –C[double bond, length as m-dash]H), 12.02 (brs, 1H, –NH, D2O exchangeable), 6.89–7.27 (m, 3H, indole ring), 2.31 (s, 1H, –CH3), 9.32 (s, 1H, indole ring). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 164.55 (C[double bond, length as m-dash]O), 133.04 (C[double bond, length as m-dash]C), 146.87 (–C[double bond, length as m-dash]N), 142.13 (–C[double bond, length as m-dash]H), 116.24–142.54 (phenyl ring), 112.64–135.65 (indole ring), 14.23 (CH3). Analytical cal. C20H17N3O: C, 76.17; H, 5.43; N, 13.32; found: C, 76.18; H, 5.40; N, 13.34. MS (EI): (m/z) [M+˙] 317.12.
(Z)-3-Methyl-4-((4-oxo-4H-chromen-3-yl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one (2d). Red crystalline solid, yield 98%, mp 222 °C. IR (KBr, cm−1): 1153, 1452 (C[double bond, length as m-dash]Caromatic), 1600 (C[double bond, length as m-dash]N), 1692 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.12–7.34 (m, 5H, phenyl ring), 7.99 (s, 1H, –C[double bond, length as m-dash]H), 10.64 (s, 1H, γ-pyrone ring), 8.19–7.27 (m, 4H, chromone ring), 2.33 (s, 1H, –CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 163.35 (C[double bond, length as m-dash]O), 134.67 (C[double bond, length as m-dash]C, C-1′), 137.81 (–C[double bond, length as m-dash]N), 155.47 (–C[double bond, length as m-dash]H, C-2′), 118.38–142.54 (phenyl ring), 150.67 (C-2, γ-pyrone ring), 118.54 (C-3), 174.29 (C-4, C[double bond, length as m-dash]O, γ-pyrone ring) 14.23 (CH3), 123.10 (C-4a), 125.75 (C-5), 124.56 (C-6), 135.92 (C-7), 117.59 (C-8), 161.83 (C-8b). Analytical cal. C20H14N2O3: C, 72.72; H, 4.27; N, 8.48; found: C, 72.70; H, 4.30; N, 8.47. MS (EI): (m/z) [M+˙] 330.10.
(Z)-3-Methyl-4-((6-methyl-4-oxo-4H-chromen-3-yl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one (2e). Orange solid, yield 95%, mp 230 °C. IR (KBr, cm−1): 1156, 1456 (C[double bond, length as m-dash]Caromatic), 1598 (C[double bond, length as m-dash]N), 1699 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.10–7.31 (m, 5H, phenyl ring), 7.69 (s, 1H, –C[double bond, length as m-dash]H), 10.04 (s, 1H, γ-pyrone ring), 8.09–7.20 (m, 3H, chromone ring), 2.30 (s, 1H, –CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 163.05 (C[double bond, length as m-dash]O), 134.17 (C[double bond, length as m-dash]C, C-1′), 137.61 (–C[double bond, length as m-dash]N), 155.27 (–C[double bond, length as m-dash]H, C-2′), 118.21–142.24 (phenyl ring), 150.22 (C-2, γ-pyrone ring), 118.74 (C-3), 174.19 (C-4, C[double bond, length as m-dash]O, γ-pyrone ring), 14.13 (CH3), 123.18 (C-4a), 125.32 (C-5), 124.56 (C-6), 135.52 (C-7), 117.49 (C-8), 161.53 (C-8b). Analytical cal. C21H16N2O3: C, 73.24; H, 4.68; N, 8.13; found: C, 73.26; H, 4.69; N, 8.10. MS (EI): (m/z) [M+˙] 344.12.
(Z)-4-((6-Fluoro-4-oxo-4H-chromen-3-yl)methylene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (2f). Red solid, yield 96%, mp 214 °C. IR (KBr, cm−1): 1157, 1455 (C[double bond, length as m-dash]Caromatic), 1599 (C[double bond, length as m-dash]N), 1696 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.02–7.11 (m, 5H, phenyl ring), 7.72 (s, 1H, –C[double bond, length as m-dash]H), 10.12 (s, 1H, γ-pyrone ring), 8.07–7.23 (m, 3H, chromone ring), 2.31 (s, 1H, –CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 163.25 (C[double bond, length as m-dash]O), 134.19 (C[double bond, length as m-dash]C, C-1′), 137.41 (–C[double bond, length as m-dash]N), 155.23 (–C[double bond, length as m-dash]H, C-2′), 118.27–142.21 (phenyl ring), 150.29 (C-2, γ-pyrone ring), 118.64 (C-3), 174.69 (C-4, C[double bond, length as m-dash]O, γ-pyrone ring), 14.18 (CH3), 123.38 (C-4a), 125.30 (C-5), 124.52 (C-6), 135.56 (C-7), 117.41 (C-8), 161.50 (C-8b). Analytical cal. C20H13FN2O3: C, 68.96; H, 3.76; N, 8.04; found: C, 68.97; H, 3.78; N, 8.01. MS (EI): (m/z) [M+˙] 348.09.
(Z)-4-((6-Bromo-4-oxo-4H-chromen-3-yl)methylene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (2g). Brown solid, yield 94%, mp 248 °C. IR (KBr, cm−1): 1158, 1451 (C[double bond, length as m-dash]Caromatic), 1580 (C[double bond, length as m-dash]N), 1699 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.42–7.18 (m, 5H, phenyl ring), 7.76 (s, 1H, –C[double bond, length as m-dash]H), 10.10 (s, 1H, γ-pyrone ring), 8.03–7.21 (m, 3H, chromone ring), 2.35 (s, 1H, –CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 163.23 (C[double bond, length as m-dash]O), 133.19 (C[double bond, length as m-dash]C, C-1′), 137.31 (–C[double bond, length as m-dash]N), 155.54 (–C[double bond, length as m-dash]H, C-2′), 118.19–142.29 (phenyl ring), 150.24 (C-2, γ-pyrone ring), 118.64 (C-3), 174.47 (C-4, C[double bond, length as m-dash]O, γ-pyrone ring), 14.22 (CH3), 123.34 (C-4a), 125.39 (C-5), 120.41(C-6), 135.36 (C-7), 117.46 (C-8), 161.76 (C-8b). Analytical cal. C20H13BrN2O3: C, 58.70; H, 3.20; N, 6.85; found: C, 58.71; H, 3.22; N, 6.82. MS (EI): (m/z) [M+˙] 408.01.
(Z)-4-((2-Amino-4-oxo-4H-chromen-3-yl)methylene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (2h). Brown solid, yield 95%, mp 240 °C. IR (KBr, cm−1): 1157, 1450 (C[double bond, length as m-dash]Caromatic), 1580 (C[double bond, length as m-dash]N), 1681 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.32–7.17 (m, 5H, phenyl ring), 7.72 (s, 1H, –C[double bond, length as m-dash]H), 8.57 (s, 2H, –NH, D2O exchangeable), 8.08–7.27 (m, 4H, chromone ring), 2.33 (s, 1H, –CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 163.28 (C[double bond, length as m-dash]O), 133.29 (C[double bond, length as m-dash]C, C-1′), 137.38 (–C[double bond, length as m-dash]N), 155.34 (–C[double bond, length as m-dash]H, C-2′), 118.25–142.37 (phenyl ring), 170.24 (C-2, γ-pyrone ring), 118.61 (C-3), 174.41 (C-4, C[double bond, length as m-dash]O, γ-pyrone ring), 14.22 (CH3), 123.28 (C-4a), 125.33 (C-5), 123.41(C-6), 135.16 (C-7), 117.26 (C-8), 161.66 (C-8b). Analytical cal. C20H15N3O3: C, 69.56; H, 4.38; N, 12.17; found: C, 69.53; H, 4.39; N, 12.19. MS (EI): (m/z) [M+˙] 345.11.
(Z)-4-(3,4-Dimethoxybenzylidene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (2i). Yellow solid, yield 97%, mp 208 °C. IR (KBr, cm−1): 1157, 1450 (C[double bond, length as m-dash]Caromatic), 1578 (C[double bond, length as m-dash]N), 1700 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.19–7.97 (m, 5H, phenyl ring), 7.32 (s, 1H, –C[double bond, length as m-dash]H), 7.28–7.32 (m, 3H, phenyl ring), 2.31 (s, 1H, –CH3), 3.38 (s, 6H, 2 × –OCH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 163.26 (C[double bond, length as m-dash]O), 133.22 (C[double bond, length as m-dash]C, C-1′), 155.14 (–C[double bond, length as m-dash]H, C-2′), 137.32 (–C[double bond, length as m-dash]N), 118.21–142.39 (phenyl ring), 128.24 (C-1), 115.23 (C-2), 148.61 (C-3), 149.41 (C-4), 111.74 (C-5), 122.25 (C-6), 14.62 (CH3), 56.06 (O–CH3). Analytical cal. C19H18N2O3: C, 70.79; H, 5.63; N, 8.69; found: C, 70.71; H, 5.60; N, 8.71. MS (EI): (m/z) [M+˙] 322.13.
(Z)-3-Methyl-1-phenyl-4-(3,4,5-trimethoxybenzylidene)-1H-pyrazol-5(4H)-one (2j). Yellow crystalline solid, yield 94%, mp 214 °C. IR (KBr, cm−1): 1150, 1456 (C[double bond, length as m-dash]Caromatic), 1600 (C[double bond, length as m-dash]N), 1691 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.19–7.97 (m, 5H, phenyl ring), 7.35 (s, 1H, –C[double bond, length as m-dash]H), 7.12 (s, 2H, phenyl ring), 2.32 (s, 1H, –CH3), 3.34 (s, 9H, 3 × –OCH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 163.28 (C[double bond, length as m-dash]O), 133.29 (C[double bond, length as m-dash]C, C-1′), 155.39 (–C[double bond, length as m-dash]H, C-2′), 137.38 (–C[double bond, length as m-dash]N), 118.52–142.29 (phenyl ring), 129.24 (C-1), 105.13 (C-2 and C-6), 154.11 (C-3 and C-4), 134.34 (C-5), 14.89 (CH3), 56.36 (O–CH3). Analytical cal. C20H20N2O4: C, 68.17; H, 5.72; N, 7.95; found: C, 68.20; H, 5.70; N, 7.94. MS (EI): (m/z) [M+˙] 352.14.
(Z)-3-Methyl-4-(4-nitrobenzylidene)-1-phenyl-1H-pyrazol-5(4H)-one (2k). Orange crystalline solid, yield 97%, mp 210 °C. IR (KBr, cm−1): 1157, 1456 (C[double bond, length as m-dash]Caromatic), 1578 (C[double bond, length as m-dash]N), 1687 (C[double bond, length as m-dash]O), 1522, 1365 (NO2). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.20–7.99 (m, 5H, phenyl ring), 7.49 (s, 1H, –C[double bond, length as m-dash]H), 8.12 (d, 2H, C-2 and C-6), 8.18 (d, 2H, C-3 and C-5), 2.36 (s, 1H, –CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 163.25 (C[double bond, length as m-dash]O), 128.21 (C[double bond, length as m-dash]C, C-1′), 145.69 (–C[double bond, length as m-dash]H, C-2′), 145.88 (–C[double bond, length as m-dash]N), 118.12–142.22 (phenyl ring), 139.24 (C-1), 132.17 (C-2 and C-6), 124.18 (C-3 and C-4), 148.14 (C-5), 15.09 (CH3). Analytical cal. C17H13N3O3: C, 66.44; H, 4.26; N, 13.67; found: C, 66.41; H, 4.28; N, 13.68. MS (EI): (m/z) [M+˙] 307.10.
(Z)-3-Methyl-4-(3-nitrobenzylidene)-1-phenyl-1H-pyrazol-5(4H)-one (2l). Yellow solid, yield 94%, mp 202 °C. IR (KBr, cm−1): 1152, 1454 (C[double bond, length as m-dash]Caromatic), 1579 (C[double bond, length as m-dash]N), 1693 (C[double bond, length as m-dash]O), 1520, 1360 (NO2). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.22–7.95 (m, 5H, phenyl ring), 7.47 (s, 1H, –C[double bond, length as m-dash]H), 7.67–8.42 (m, 4H, phenyl ring), 2.32 (s, 1H, –CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 163.29 (C[double bond, length as m-dash]O), 127.23 (C[double bond, length as m-dash]C, C-1′), 144.63 (–C[double bond, length as m-dash]H, C-2′), 146.98 (–C[double bond, length as m-dash]N), 118.15–142.32 (phenyl ring), 133.34 (C-1), 125.17 (C-2), 147.08 (C-3), 123.08 (C-4), 128.18 (C-5), 123.36 (C-6), 15.19 (CH3). Analytical cal. C17H13N3O3: C, 66.44; H, 4.26; N, 13.67; found: C, C, 66.41; H, 4.27; N, 13.69. MS (EI): (m/z) [M+˙] 307.10.
(Z)-4-(4-(Dimethylamino)benzylidene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (2m). Orange crystalline solid, yield 98%, mp 194 °C, reported 188–192 °C.39 IR (KBr, cm−1): 1154, 1452 (C[double bond, length as m-dash]Caromatic), 1591 (C[double bond, length as m-dash]N), 1689 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.13–7.97 (m, 5H, phenyl ring), 7.58 (s, 1H, –C[double bond, length as m-dash]H), 2.30 (s, 1H, –CH3), 6.84–8.66 (m, 4H, phenyl ring), 3.13 (s, 1H, 2 × CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 170.16 (C[double bond, length as m-dash]O), 128.69 (C[double bond, length as m-dash]C, C-1′), 151.56 (–C[double bond, length as m-dash]H, C-2′), 153.80. (–C[double bond, length as m-dash]N), 118.09–138.84 (phenyl ring), 123.92 (C-1), 137.43 (C-2 and C-6), 111.32 (C-3 and C-5), 148.18 (C-4), 15.19 (CH3), 41.28 (N–CH3). Analytical cal. C19H19N3O: C, 74.73; H, 6.27; N, 13.76; found: C, 74.70; H, 6.28; N, 13.78. MS (EI): (m/z) [M+˙] 305.15.
(Z)-4-(4-Fluorobenzylidene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (2n). Yellow solid, yield 96%, mp 104 °C, reported 98–102 °C.39 IR (KBr, cm−1): 1156, 1455 (C[double bond, length as m-dash]Caromatic), 1593 (C[double bond, length as m-dash]N), 1697 (C[double bond, length as m-dash]O). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.19–7.97 (m, 5H, phenyl ring), 7.42 (s, 1H, –C[double bond, length as m-dash]H), 2.34 (s, 1H, –CH3), 7.14–7.86 (m, 4H, phenyl ring). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 168.12 (C[double bond, length as m-dash]O), 127.60 (C[double bond, length as m-dash]C, C-1′), 145.50 (–C[double bond, length as m-dash]H, C-2′), 148.85. (–C[double bond, length as m-dash]N), 118.02–139.81 (phenyl ring), 128.91 (C-1), 132.03 (C-2 and C-6), 115.36 (C-3 and C-5), 162.18 (C-4), 15.02 (CH3). Analytical cal. C17H13FN2O: C, 72.85; H, 4.67; N, 9.99; found: C, 72.82; H, 4.69; N, 10.00. MS (EI): (m/z) [M+˙] 280.10.
(Z)-4-Benzylidene-1-(2,4-dinitrophenyl)-3-methyl-1H-pyrazol-5(4H)-one (2o). Yellow solid, yield 94%, mp 194 °C.40 IR (KBr, cm−1): 1152, 1450 (C[double bond, length as m-dash]Caromatic), 1597 (C[double bond, length as m-dash]N), 1686 (C[double bond, length as m-dash]O), 1528, 1368 (NO2). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 8.20–9.08 (m, 3H, phenyl ring), 7.42 (s, 1H, –C[double bond, length as m-dash]H), 2.36 (s, 1H, –CH3), 7.40–7.66 (m, 5H, phenyl ring). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 170.12 (C[double bond, length as m-dash]O), 126.69 (C[double bond, length as m-dash]C, C-1′), 150.56 (–C[double bond, length as m-dash]H, C-2′), 150.80. (–C[double bond, length as m-dash]N), 120.14–144.09 (phenyl ring), 123.02 (C-1), 136.43 (C-2 and C-6), 111.48 (C-3 and C-5), 148.88 (C-4), 15.20 (CH3). Analytical cal. C17H12N4O5: C, 57.96; H, 3.43; N, 15.90; found: C, 57.93; H, 3.45; N, 15.91. MS (EI): (m/z) [M+˙] 352.08.
(Z)-1-(2,4-Dinitrophenyl)-3-methyl-4-(3-nitrobenzylidene)-1H-pyrazol-5(4H)-one (2p). Yellow crystalline solid, yield 95%, mp 274 °C, reported 272–274 °C.41 IR (KBr, cm−1): 1152, 1454 (C[double bond, length as m-dash]Caromatic), 1593 (C[double bond, length as m-dash]N), 1700 (C[double bond, length as m-dash]O), 1520, 1360 (NO2). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 8.22–9.02 (m, 3H, phenyl ring), 7.54 (s, 1H, –C[double bond, length as m-dash]H), 7.68–8.30 (m, 4H, phenyl ring), 2.34 (s, 1H, –CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 164.20 (C[double bond, length as m-dash]O), 127.10 (C[double bond, length as m-dash]C, C-1′), 144.03 (–C[double bond, length as m-dash]H, C-2′), 146.99 (–C[double bond, length as m-dash]N), 120.15–145.32 (phenyl ring), 133.04 (C-1), 124.17 (C-2), 147.88 (C-3), 123.28 (C-4), 128.28 (C-5), 122.06 (C-6), 15.20 (CH3). Analytical cal. C17H11N5O7: C, 51.39; H, 2.79; N, 17.63; found: C, 51.36; H, 2.80; N, 17.65. MS (EI): (m/z) [M+˙] 397.30.
(Z)-4-(3,4-Dimethoxybenzylidene)-1-(2,4-dinitrophenyl)-3-methyl-1H-pyrazol-5(4H)-one (2q). Yellow solid, yield 97%, mp 224 °C.40 IR (KBr, cm−1): 1157, 1456 (C[double bond, length as m-dash]Caromatic), 1594 (C[double bond, length as m-dash]N), 1688 (C[double bond, length as m-dash]O), 1522, 1362 (NO2). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 8.20–9.04 (m, 3H, phenyl ring), 7.46 (s, 1H, –C[double bond, length as m-dash]H), 7.20–7.31 (m, 3H, phenyl ring), 2.32 (s, 1H, –CH3), 3.36 (s, 6H, 2 × –OCH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 164.26 (C[double bond, length as m-dash]O), 130.22 (C[double bond, length as m-dash]C, C-1′), 150.14 (–C[double bond, length as m-dash]H, C-2′), 139.32 (–C[double bond, length as m-dash]N), 120.21–144.39 (phenyl ring), 128.14 (C-1), 115.53 (C-2), 148.68 (C-3), 149.45 (C-4), 111.72 (C-5), 122.25 (C-6), 14.88 (CH3), 56.02 (O–CH3). Analytical cal. C19H16N4O7: C, 55.34; H, 3.91; N, 13.59; found: C, 55.31; H, 3.93; N, 13.60. MS (EI): (m/z) [M+˙] 412.10.
(Z)-4-(4-(Dimethylamino)benzylidene)-1-(2,4-dinitrophenyl)-3-methyl-1H-pyrazol-5(4H)-one (2r). Orange crystalline solid, yield 98%, mp 240 °C.40 IR (KBr, cm−1): 1156, 1452 (C[double bond, length as m-dash]Caromatic), 1593 (C[double bond, length as m-dash]N), 1691 (C[double bond, length as m-dash]O), 1526, 1361 (NO2). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 8.28–9.01 (m, 3H, phenyl ring), 7.49 (s, 1H, –C[double bond, length as m-dash]H), 2.32 (s, 1H, –CH3), 6.80–8.46 (m, 4H, phenyl ring), 3.10 (s, 1H, 2 × CH3). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 170.12 (C[double bond, length as m-dash]O), 126.69 (C[double bond, length as m-dash]C, C-1′), 150.56 (–C[double bond, length as m-dash]H, C-2′), 150.80. (–C[double bond, length as m-dash]N), 120.14–144.09 (phenyl ring), 123.02 (C-1), 136.43 (C-2 and C-6), 111.48 (C-3 and C-5), 148.88 (C-4), 15.20 (CH3), 41.31 (N–CH3). Analytical cal. C19H17N5O5: C, 57.72; H, 4.33; N, 17.71; found: C, 57.73; H, 4.30; N, 17.73. MS (EI): (m/z) [M+˙] 395.12.
(Z)-1-(2,4-Dinitrophenyl)-4-(4-fluorobenzylidene)-3-methyl-1H-pyrazol-5(4H)-one (2s). Yellow solid, yield 94%, mp 162 °C, reported 160–163 °C.41 IR (KBr, cm−1): 1159, 1453 (C[double bond, length as m-dash]Caromatic), 1598 (C[double bond, length as m-dash]N), 1698 (C[double bond, length as m-dash]O), 1526, 1360 (NO2). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 7.96–7.98 (m, 3H, phenyl ring), 7.42 (s, 1H, –C[double bond, length as m-dash]H), 2.36 (s, 1H, –CH3), 7.18–7.80 (m, 4H, phenyl ring). 13C NMR (100 MHz, DMSO-d6, δ, ppm): 169.10 (C[double bond, length as m-dash]O), 127.60 (C[double bond, length as m-dash]C, C-1′), 145.50 (–C[double bond, length as m-dash]H, C-2′), 148.85. (–C[double bond, length as m-dash]N), 120.23–145.84 (phenyl ring), 128.91 (C-1), 132.00 (C-2 and C-6), 115.31 (C-3 and C-5), 162.18 (C-4), 15.01 (CH3). Analytical cal. C17H11FN4O5: C, 55.14; H, 2.99; N, 15.13; found: C, 55.15; H, 2.96; N, 15.15. MS (EI): (m/z) [M+˙] 370.07.

Single crystal X-ray crystallographic studies of compound 2a and 2d

Single crystal X-ray data of compounds 2a and 2d were collected at 100 K on a Bruker SMART APEX CCD diffractometer using graphite monochromated MoKα radiation (λ = 0.71073 Å). The linear absorption coefficients, scattering factors for the atoms and the anomalous dispersion corrections were taken from the International Tables for X-ray crystallography.42 The data integration and reduction were carried out with SAINT software.43 An empirical absorption correction was applied to the collected reflections with SADABS, and the space group was determined using XPREP.44 The structure was solved by direct methods using SHELXTL-97 and refined on F2 by full-matrix least-squares using the SHELXL-97 (ref. 45) program package. All non-hydrogen atoms were refined anisotropically. Pertinent crystallographic data for compounds 2a and 2d are summarized in Table 5. The crystal data have been deposited at the Cambridge Crystallographic Data Centre (CCDC) with reference number, compound 2a with CCDC 1409997 and compound 2d with CCDC 1432605.

Conclusion

In summary, we have developed a simple, efficient, cost effective and green procedure for one-pot synthesis of a series of pyrazolone derivatives 2(a–s) in excellent yields (94–98%) by employing recyclable and reusable SiO2/ZnBr2 Lewis acid catalyst in water under microwave heating. The scheme not only offers use of microwave at low temperature and substantial yield of products but also affords mild reaction conditions, water as a green solvent, shorter reaction times, high purity, operational simplicity and easy workup. We believe that this synthetic approach provides a better scope for the synthesis of pyrazolone analogues and will be a more practical alternative to the other existing methods.

Acknowledgements

S. Azaz thanks the Chairman, Department of Chemistry, AMU, Aligarh, for providing the necessary research facilities. USIF, AMU is acknowledged for SEM-EDX analysis. Department of Physics, AMU, Aligarh is acknowledged for XRD analysis. SAIF, Panjab University, Chandigarh is acknowledged for spectral analysis. IIT Kanpur is also acknowledged for X-ray analysis. UGC is also gratefully acknowledged for research fellowship to S. Azaz and F. Ahmad.

References

  1. R. Ballini, Eco-Friendly Synthesis of Fine Chemicals, Royal Society of Chemistry, 2009 Search PubMed.
  2. M. Parveen, F. Ahmad, A. M. Malla and S. Azaz, New J. Chem., 2015, 39, 2028 RSC.
  3. S. Rasapalli, Y. Fan, M. Yu, C. Rees, J. T. Harris, J. A. Golen, J. P. Jasinski, A. L. Rheingold, S. M. Kwasny and T. J. Opperman, Bioorg. Med. Chem. Lett., 2013, 23, 3235 CrossRef CAS PubMed.
  4. A. Gursoy, S. Demirayak, G. Capan, K. Erol and K. Vural, Eur. J. Med. Chem., 2000, 35, 359 CrossRef CAS PubMed.
  5. D. Castagnolo, F. Manetti, M. Radi, B. Bechi, M. Pagano, A. D. Logu, R. Meleddu, M. Saddi and M. Botta, Bioorg. Med. Chem., 2009, 17, 5716 CrossRef CAS PubMed.
  6. N. Parekh, K. Maheria, P. Patel and M. Rathod, Int. J. PharmTech Res., 2011, 3, 540 CAS.
  7. G. Mariappan, B. P. Saha, L. Sutharson and A. Haldar, Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem., 2010, 49, 1671 Search PubMed.
  8. P. Manojkumar, T. Ravi and G. Subbuchettiar, Acta Pharm., 2009, 59, 159 CrossRef CAS PubMed.
  9. H. Kawai, H. Nakai, M. Suga, S. Yuki, T. Watanabe and K. I. Saito, J. Pharmacol. Exp. Ther., 1997, 281, 921 CAS.
  10. F. X. Jarreau and J. J. Koenig, US Pat., 4526, 895, 1985Chem. Abstr. 1996, 97, 225, 868/20.
  11. A. R. Farghaly, ARKIVOC, 2010, xi, 177 Search PubMed.
  12. Y. Kakiuchi, N. Sasaki, M. Satoh-Masuoka, H. Murofushi and K. Murakami-Murofushi, Biochem. Biophys. Res. Commun., 2004, 320, 1351 CrossRef CAS PubMed.
  13. M. Arnost, A. Pierce, E. Haar, D. Lauffer, J. Madden, K. Tanner and J. Green, Bioorg. Med. Chem. Lett., 2010, 20, 1661 CrossRef CAS PubMed.
  14. L. F. Tietze and A. Steinmetz, Synlett, 1996, 667 CrossRef CAS.
  15. X. L. Li, H. Ma, Y. M. Wang and J. M. Meng, Chem. J. Chin. Univ., 1995, 16, 1903 CAS.
  16. M. N. Elinson, A. S. Dorofeev, R. F. Nasybullin and G. I. Nikishin, Synthesis, 2008, 1933 CrossRef CAS.
  17. H. Zang, Q. Su, Y. Mo and B. Cheng, Ultrason. Sonochem., 2011, 18, 68 CrossRef CAS PubMed.
  18. R. Verma, P. Chawla and S. K. Saraf, Pharma Chem., 2012, 3, 546 CAS.
  19. D. Singh and D. Singh, J. Chem. Eng. Data, 1984, 29, 355 CrossRef CAS.
  20. K. Niknam, D. Saberi, M. Sadegheyan and A. Deris, Tetrahedron Lett., 2010, 51, 692 CrossRef CAS.
  21. W. Wang, S. X. Wang, X. Y. Qin and J. T. Li, Synth. Commun., 2005, 35, 1263 CrossRef CAS.
  22. K. Sujatha, G. Shanthi, N. P. Selvam, S. Manoharan, P. T. Perumal and M. Rajendran, Bioorg. Med. Chem. Lett., 2009, 19, 4501 CrossRef CAS PubMed.
  23. D. Q. Shi, J. Chen, N. Wu, Q. Y. Zhuang and X. S. Wang, Chin. J. Org. Chem., 2005, 25, 405 CAS.
  24. J. Cai, Z. Zhou, G. Zhao and C. Tang, Org. Lett., 2002, 4, 4723 CrossRef CAS PubMed.
  25. R. Breslo, Acc. Chem. Res., 1991, 24, 159 CrossRef.
  26. U. M. Lindström, Chem. Rev., 2002, 102, 2751 CrossRef.
  27. N. E. Leadbeater and M. Marco, Org. Lett., 2002, 4, 2973 CrossRef CAS PubMed.
  28. A. M. Malla, M. Parveen, F. Ahmad, S. Azaz and M. Alam, RSC Adv., 2015, 5, 19552 RSC.
  29. M. Parveen, F. Ahmad, A. M. Malla, S. Azaz, M. R. Silva and P. S. P. Silva, RSC Adv., 2015, 5, 52330 RSC.
  30. M. Parveen, S. Azaz, A. M. Malla, F. Ahmad, P. S. P. Silva and M. R. N. Silva, New J. Chem., 2015, 39, 469 RSC.
  31. A. Keivanloo, M. Bakherad, B. Bahramian and S. Baratnia, Tetrahedron Lett., 2011, 52, 1498 CrossRef CAS.
  32. A. Keivanloo, M. Bakherad, S. A. N. Taheri and S. Samangooei, C. R. Chim., 2013, 16, 239 CrossRef CAS.
  33. M. Kodomari, M. Nagamatsu, M. Akaike and T. Aoyama, Tetrahedron Lett., 2008, 49, 2537 CrossRef CAS.
  34. J. H. Clark, J. C. Ross, D. J. Macquarrie, S. J. Barlowb and T. W. Bastock, Chem. Commun., 1997, 1203 RSC.
  35. S. Wang, Z. Zhang, B. Liu and J. Li, Catal. Sci. Technol., 2013, 3, 2104 CAS.
  36. G. Fan, S. Luo, Q. Wu, T. Fang, J. Li and G. Song, RSC Adv., 2015, 5, 56478 RSC.
  37. B. Datta and M. A. Pasha, ISRN Org. Chem., 2013, 2013, 132794 CrossRef PubMed , 5 pages.
  38. M. Parveen, A. M. Malla, M. Alam, M. Ahmad and S. Rafiq, New J. Chem., 2014, 38, 1655 RSC.
  39. R. Verma, P. Chawla and S. K. Saraf, Pharma Chem., 2012, 3, 546 CAS.
  40. S. P. Prajapati, D. P. Patel and P. S. Patel, Elixir Org. Chem., 2012, 48, 9414 Search PubMed.
  41. K. Bhanat, B. Parashar and V. K. Sharma, Eur. Chem. Bull., 2014, 3, 489 CAS.
  42. C. H. MacGillavry, G. D. Rieck and K. Lonsdale, International Tables for X-Ray Crystallography, Kynoch Press, Birmingham, England, 1952, vol. III Search PubMed.
  43. SAINT, Version 6.02, Bruker AXS, Madison, WI, 1999 Search PubMed.
  44. XPREP, Version 5.1, Siemens Industrial Automation Inc., Madison, WI, 1995 Search PubMed.
  45. G. M. Sheldrick, SHELXL-97: Program for Crystal Structure Refinement, University of Göttingen, Göttingen, Germany, 1997 Search PubMed.

Footnote

Electronic supplementary information (ESI) available. CCDC 1409997 and 1432605. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra21146h

This journal is © The Royal Society of Chemistry 2016